Lobe Sciences Ltd. , a biopharmaceutical company focused on developing transformative medicines to treat rare diseases and Clearway Global, LLC , a wholly owned subsidiary of Sancilio & Company , a.
Quality Chemical Laboratories LLC ("QCL") has developed a synthetic pathway for psilocybin, psilocin and psilocin analogues exclusively for Lobe SciencesQCL agrees to supply Lobe Sciences research and
Vancouver, British Columbia (Newsfile Corp. - June 21, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBED) ("Lobe" or the "Company"), a Canadian Biopsychedelics company committed to discovering and
The Global Short Bowel Syndrome (SBS) Market report predicts the market size during 2022-2026, and the markets growth momentum will accelerate at a CAGR of Short Bowel Syndrome (SBS) market.